Contract Notice Detail

Summary Information

Summary Information
67,316.40 Euro
 
 
AD 106/2023 
AD 106/2023 Aquisição do Medicamento Darunavir 800 mg + Cobicistate 150 mg + Emtricitabina 200 mg + Tenofovir (CP 2022/40) 
Tendering Phase
Awarded
VortalGOV - Acquisition under a Framework Agreement (via Direct Award) 
Lot NameLot Base PriceExpected Duration
D559 - DARUNAVIR + COBICISTATE + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [800 + 150 + 200 + 10 MG; COMP]67,316.40 Euro6 (Months)

Object of the Contract

Object of the Contract
Supplies Acquisition 
Quinta do Alvito 6200-251 Covilhã Castelo Branco PORTUGAL  
33600000-6 - Pharmaceutical products
 
 
 

Scheduling

Scheduling
11/27/2023 10:19 AM (UTC 0 hours)
 
1/19/2022 9:00 AM (UTC 0 hours)
 
11/30/2023 5:00 PM (UTC 0 hours)
 

Financial Settings

Financial Settings
No 
No 

Contract Documents

Contract Documents
Document NameDescriptionDoc Classification
No items found...

Object of contract

No 
No 

Legal, economic, financial and technical information

No 

Questionnaire

Questionnaire
 
 
 1 
Questionário
 1.1  
 Lote 1Section for Lot - D559 - DARUNAVIR + COBICISTATE + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [800 + 150 + 200 + 10 MG; COMP]
 1.1.1   
Lote 1
Bill of Quantities *
(Os valores indicados não incluem o IVA)
Solicitou requisitos adicionais nesta lista de preços.
     
Preço Total
0,00
EUR
     
 
Cód. ArtigoReferência InternaDescriçãoQtUnidadePreço UnitárioPreço Total
     
D559
DARUNAVIR + COBICISTATE + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [800 + 150 + 200 + 10 MG; COMP]
2 700,000000
UN
 
500189412 | Janssen - Cilag Farmacêutica, Lda. | CPA:2022040/74/0089 | NºAIM:5728373;
  

Public Messages

Public Messages
TypeReferenceSubjectDate
No items found...